Key result
Statin therapy at the time of emergency PCI for STEMI with cardiogenic shock was associated with lower in-hospital mortality.
Why the study?
Does statin therapy reduce in-hospital mortality in patients undergoing emergency PCI for STEMI complicated by cardiogenic shock?
Cohort (n=111)
Does statin therapy reduce in-hospital mortality in patients undergoing emergency PCI for STEMI complicated by cardiogenic shock?
Statin therapy at the time of emergency PCI for STEMI complicated by cardiogenic shock is associated with significantly improved in-hospital survival.
Answers are grounded in this paper and cite their sources.
May support statin use during emergency PCI for STEMI shock; leaves open randomized confirmation of survival benefit.
AIMS: Long-term administration of statin therapy has been shown to reduce major coronary events and cardiac mortality within randomised clinical trials. Statins favourably affect platelet adhesion, thrombosis, endothelial function, inflammation, plaque stability, and ventricular arrhythmia, which may potentially improve outcome after percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) and shock. Therefore, we hypothesised that statin therapy has an early beneficial effect among patients undergoing PCI for STEMI complicated by cardiogenic shock. METHODS AND RESULTS: We retrospectively collected data of consecutive patients undergoing emergency PCI for STEMI complicated by cardiogenic shock between January 2000 and June 2008. Baseline, procedural, and in-hospital data of statin-treated and non-statin-treated patients were compared. Propensity score and multivariate survival analysis were used to adjust for heterogeneity between the two groups. Of 111 patients who comprised the study population, 30/111 (27%) were treated with statin at the time of the procedure. Statin therapy was associated with an in-hospital mortality reduction (46.7% versus 70.4%; odds ratio, 0.32; 95% CI, 0.11-0.89; P=0.029). After adjusting for the propensity to receive statin therapy before the procedure and other confounders, statin therapy remained an independent predictor for in-hospital survival after coronary intervention (odds ratio, 0.35; 95% CI, 0.15 to 0.88; P=0.026). CONCLUSIONS: In this study cohort, statin therapy among patients undergoing emergency PCI for STEMI and cardiogenic shock is associated with a significant mortality advantage at early follow-up.
No takes yet. Share an insight, caveat, or question.
Garot et al. (2010) conducted a cohort in STEMI complicated by cardiogenic shock (n=111). Statin therapy at the time of procedure vs. No statin therapy was evaluated on In-hospital mortality (OR 0.32, 95% CI 0.11-0.89, p=0.029). Statin therapy at the time of emergency PCI for STEMI with cardiogenic shock was associated with lower in-hospital mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: